Stem cell markers can help identify adnexal tumor differentiation when evaluated in the context of morphology: Methodology matters

Journal of Cutaneous Pathology

Volumn 38, Issue 6, 2011, Pages 460-474

  Sellheyer, Klaus ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Nelson Dermatopathology Associates   (United States)

Author keywords

adnexal tumors; CD200; cytokeratin 15; PHLDA1; stem cell markers

Indexed keywords

TUMOR MARKER;

CELL DIFFERENTIATION; CELL LINEAGE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; STEM CELL; SWEAT GLAND TUMOR;

CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955529614     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01671.x     Document Type: Review

References (86)

1. Yu BD, Mukhopadhyay A, Wong C., Skin and hair: models for exploring organ regeneration. Hum Mol Genet 2008; 17: R54.
2. Paus R, Peker S., Biology of hair and nails. In, Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology, Vol. 1. Edinburgh, London, New York: Mosby, 2003; 1007.
3. Meyer KC, Klatte JE, Dinh HV, et al., Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 2008; 159: 1077.
4. Ohyama M, Terunuma A, Tock CL, et al., Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006; 116: 249.
5. Ito M, Liu Y, Yang Z, et al., Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med 2005; 11: 1351.
6. Nakamura M, Tokura Y., The localization of label-retaining cells in eccrine glands. J Invest Dermatol 2009; 129: 2077.
7. McCalmont TH., A call for logic in the classification of adnexal neoplasms. Am J Dermatopathol 1996; 18: 103.
8. McCalmont TH., Batman and adnexal tumors. J Cutan Pathol 2010; 37: 401.
9. Brooke JD, Fitzpatrick JE, Golitz LE., Papillary mesenchymal bodies: a histologic finding useful in differentiating trichoepitheliomas from basal cell carcinomas. J Am Acad Dermatol 1989; 21: 523.
10. Ackerman AB, Mones JM., Resolving quandries in dermatopathology, pathology, and dermatopathology. New York: Ardor Scribendi, 2001.
11. Takahashi K, Tanabe K, Ohnuki M, et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861.
12. Aasen T, Raya A, Barrero MJ, et al., Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26: 1276.
13. Krahl D, Sellheyer K., Basal cell carcinoma and pilomatrixoma mirror human follicular embryogenesis as reflected by their differential expression patterns of SOX9 and beta-catenin. Br J Dermatol 2010; 162: 1294.
14. Akiyama M, Smith LT, Shimizu H., Changing patterns of localization of putative stem cells in developing human hair follicles. J Invest Dermatol 2000; 114: 321.
15. Schneider MR, Schmidt-Ullrich R, Paus R., The hair follicle as a dynamic miniorgan. Curr Biol 2009; 19: R132.
16. Cotsarelis G, Sun TT, Lavker RM., Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990; 61: 1329.
17. Horsley V, O'Carroll D, Tooze R, et al., Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell 2006; 126: 597.
18. Sellheyer K, Krahl D., Blimp-1: a marker of terminal differentiation but not of sebocytic progenitor cells. A comparative analysis of embryonic and adult human skin with sebaceous neoplasms. J Cutan Pathol 2010; 37: 362.
19. MagnÃ'sdõttir E, Kalachikov S, Mizukoshi K, et al., Epidermal terminal differentiation depends on B lymphocyte-induced maturation protein-1. Proc Natl Acad Sci U S A 2007; 104: 14988.
20. Frederiksen K, McKay RD., Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J Neurosci 1988; 8: 1144.
21. Li L, Mignone J, Yang M, et al., Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci U S A 2003; 100: 9958.
22. Amoh Y, Li L, Yang M, et al., Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci U S A 2004; 101: 13291.
23. Amoh Y, Li L, Campillo R, et al., Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A 2005; 102: 17734.
24. Amoh Y, Li L, Yang M, et al., Hair follicle-derived blood vessels vascularize tumors in skin and are inhibited by doxorubicin. Cancer Res 2005; 65: 2337.
25. Amoh Y, Li L, Katsuoka K, Penman S, Hoffman RM., Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci U S A 2005; 102: 5530.
26. Amoh Y, Li L, Katsuoka K, Hoffman RM., Chemotherapy targets the hair-follicle vascular network but not the stem cells. J Invest Dermatol 2007; 127: 11.
27. Mignone JL, Roig-Lopez JL, Fedtsova N, et al., Neural potential of a stem cell population in the hair follicle. Cell Cycle 2007; 6: 2161.
28. Amoh Y, Kanoh M, Niiyama S, et al., Human and mouse hair follicles contain both multipotent and monopotent stem cells. Cell Cycle 2009; 8: 176.
29. Aki R, Amoh Y, Li L, Katsuoka K, Hoffman RM., Nestin-expressing interfollicular blood vessel network contributes to skin transplant survival and wound healing. J Cell Biochem 2010; 110: 80.
30. Tiede S, Kloepper JE, Ernst N, Poeggeler B, Kruse C, Paus R., Nestin in human skin: exclusive expression in intramesenchymal skin compartments and regulation by leptin. J Invest Dermatol 2009; 129: 2711.
31. Sellheyer K, Krahl D., Spatiotemporal expression pattern of neuroepithelial stem cell marker nestin suggests a role in dermal homeostasis, neovasculogenesis and tumor stroma development. A study on embryonic and adult human skin. J Am Acad Dermatol 2010; 63: 93.
32. Sellheyer K, Krahl D., Does the peritumoral stroma of basal cell carcinoma recapitulate the follicular connective tissue sheath? A comparative analysis of nestin expression in basal cell carcinoma, trichoepithelioma, trichoblastoma, and the hair follicle. J Cutan Pathol. In press 2011.
33. Mori T, Misago N, Yamamoto O, Toda S, Narisawa Y., Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma. J Dermatol 2008; 35: 419.
34. Sellheyer K, Nelson P, Krahl D., Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells? Br J Dermatol 2009; 161: 1317.
35. Hoang MP, Keady M, Mahalingam M., Stem cell markers (cytokeratin 15, CD34 and nestin) in primary scarring and nonscarring alopecia. Br J Dermatol 2009; 160: 609.
36. Abbas O, Mahalingam M., Epidermal stem cells: practical perspectives and potential uses. Br J Dermatol 2009; 161: 228.
37. Kruse C, Bodõ E, Petschnik AE, Danner S, Tiede S, Paus R., Towards the development of a pragmatic technique for isolating and differentiating nestin-positive cells from human scalp skin into neuronal and glial cell populations: generating neurons from human skin? Exp Dermatol 2006; 15: 794.
38. Abbas O, Bhawan J., Expression of stem cell markers nestin and cytokeratin 15 and 19 in cutaneous malignancies. J Eur Acad Dermatol Venereol 2010 [Epub ahead of print].
39. Misago N, Mori T, Narisawa Y., Nestin expression in stromal cells of trichoblastoma and basal cell carcinoma. J Eur Acad Dermatol Venereol 2010; 24: 1354.
40. Lacina L, Smetana K Jr, Dvoránková B, et al., Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes. Br J Dermatol 2007; 156: 819.
41. Tallman MS, Mathews V, DiPersio JF., Role of hematopoietic stem cell transplantation in acute myelogenous leukemia and myelodysplastic syndrome. Cancer Treat Res 2009; 144: 415.
42. Chen Y, Peng C, Sullivan C, Li D, Li S., Novel therapeutic agents against cancer stem cells of chronic myeloid leukemia. Anticancer Agents Med Chem 2010; 10: 111.
43. Nickoloff BJ., The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 1991; 127: 523.
44. Trempus CS, Morris RJ, Bortner CD, et al., Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol 2003; 120: 501.
45. Trempus CS, Morris RJ, Ehinger M, et al., CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res 2007; 67: 4173.
46. Poblet E, Jimenez-Acosta F, Rocamora A., QBEND/10 (anti-CD34 antibody) in external root sheath cells and follicular tumors. J Cutan Pathol 1994; 21: 224.
47. Poblet E, Jiménez F, Godínez JM, Pascual-Martín A, Izeta A., The immunohistochemical expression of CD34 in human hair follicles: a comparative study with the bulge marker CK15. Clin Exp Dermatol 2006; 31: 807.
48. Poblet E, Jiménez F., CD10 and CD34 in fetal and adult human hair follicles: dynamic changes in their immunohistochemical expression during embryogenesis and hair cycling. Br J Dermatol 2008; 159: 646.
49. Illueca C, Monteagudo C, Revert A, Llombart-Bosch A., Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma. J Cutan Pathol 1998; 25: 435.
50. McCalmont TH, LeBoit PE., Polygonal CD34 positivity portends trichilemmal differentiation. J Cutan Pathol 2010; 37: 923.
51. Plaza JA, Ortega PF, Stockman DL, Suster S., Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol 2010; 37: 403.
52. Gleason BC, Calder KB, Cibull TL, et al., Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma. J Cutan Pathol 2009; 36: 543.
53. Dotto JE, Glusac EJ., p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2006; 33: 413.
54. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A., p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708.
55. Yang A, Schweitzer R, Sun D, et al., p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714.
56. Pellegrini G, Dellambra E, Golisano O, et al., p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001; 98: 3156.
57. Koster MI, Huntzinger KA, Roop DR., Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation. J Investig Dermatol Symp Proc 2002; 7: 41.
58. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR., p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004; 18: 126.
59. Yang A, Kaghad M, Wang Y, et al., p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305.
60. Nylander K, Vojtesek B, Nenutil R, et al., Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002; 198: 417.
61. Tsujita-Kyutoku M, Kiuchi K, Danbara N, Yuri T, Senzaki H, Tsubura A., p63 expression in normal human epidermis and epidermal appendages and their tumors. J Cutan Pathol 2003; 30: 11.
62. Qureshi HS, Ormsby AH, Lee MW, Zarbo RJ, Ma CK., The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol 2004; 31: 145.
63. Ivan D, Hafeez Diwan A, Prieto VG., Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol 2005; 18: 137.
64. Takeuchi Y, Tamura A, Kamiya M, Fukuda T, Ishikawa O., Immunohistochemical analyses of p63 expression in cutaneous tumours. Br J Dermatol 2005; 153: 1230.
65. Vidal CI, Goldberg M, Burstein DE, Emanuel HJ, Emanuel PO., p63 immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors. Am J Dermatopathol 2010; 32: 257.
66. Abbas O, Richards JE, Yaar R, Mahalingam M., Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions. Mod Pathol 2011; 24: 90.
67. Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, Cotsarelis G., The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci 1998; 111: 3179.
68. Pontiggia L, Biedermann T, Meuli M, et al., Markers to evaluate the quality and self-renewing potential of engineered human skin substitutes in vitro and after transplantation. J Invest Dermatol 2009; 129: 480.
69. Moll R, Moll I, Franke WW., Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res 1984; 276: 349.
70. Jih DM, Lyle S, Elenitsas R, Elder DE, Cotsarelis G., Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. J Cutan Pathol 1999; 26: 113.
71. Kanitakis J, Bourchany D, Faure M, Claudy A., Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol 1999; 9: 363.
72. Kurzen H, Esposito L, Langbein L, Hartschuh W., Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma. Am J Dermatopathol 2001; 23: 501.
73. Kanoh M, Amoh Y, Sato Y, Katsuoka K., Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors. Eur J Dermatol 2008; 18: 518.
74. Choi CW, Park HS, Kim YK, Lee SH, Cho KH., Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma. J Dermatol 2008; 35: 499.
75. Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M., Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Mod Pathol 2008; 21: 178.
76. Stasiak PC, Purkis PE, Leigh IM, Lane EB., Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 1989; 92: 707.
77. Lane EB, Wilson CA, Hughes BR, Leigh IM., Stem cells in hair follicles. Cytoskeletal studies. Ann N Y Acad Sci 1991; 642: 197.
78. Michel M, Török N, Godbout MJ, et al., Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 1996; 109: 1017.
79. Dvoránková B, Smetana K Jr, Chovanec M, et al., Transient expression of keratin 19 is induced in originally negative interfollicular epidermal cells by adhesion of suspended cells. Int J Mol Med 2005; 16: 525.
80. Regauer S., Extramammary Paget's disease-a proliferation of adnexal origin? Histopathology 2006; 48: 723.
81. Sellheyer K, Belbin TJ., DNA microarrays: from structural genomics to functional genomics. The applications of gene chips in dermatology and dermatopathology. J Am Acad Dermatol 2004; 51: 681.
82. Park CG, Lee SY, Kandala G, Lee SY, Choi Y., A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity 1996; 4: 583.
83. Sellheyer K, Krahl D., PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma. Br J Dermatol 2011; 164: 141.
84. Sasahara Y, Yoshikawa Y, Morinaga T, et al., Human keratinocytes derived from the bulge region of hair follicles are refractory to differentiation. Int J Oncol 2009; 34: 1191.
85. Koster MI, Roop DR., The role of p63 in development and differentiation of the epidermis. J Dermatol Sci 2004; 34: 3.
86. Koster MI, Dai D, Roop DR., Conflicting roles for p63 in skin development and carcinogenesis. Cell Cycle 2007; 6: 269.